Salix Pharmaceuticals, a specialty pharmaceutical company aimed at the prevention and treatment of gastrointestinal disorders, announced the acquisition of Santarus.
"Beginning today," said Carolyn Logan, president and CEO of Salix. "We are positioned to continue the growth of our business with an expanded portfolio of products and an expanded sales effort. Our product portfolio now offers 22 marketed products."
MIT Researchers Develop Hand-Held Eye Screening Device
Medline Launches New Products Catalog
"Beginning today," said Carolyn Logan, president and CEO of Salix. "We are positioned to continue the growth of our business with an expanded portfolio of products and an expanded sales effort. Our product portfolio now offers 22 marketed products."
More Articles on Supply Chain:
HistoSonics Announces First Treatment of BPH Patient With Vortx RX DeviceMIT Researchers Develop Hand-Held Eye Screening Device
Medline Launches New Products Catalog